VTRS vs. JNJ
VTRS (Viatris Inc.) and JNJ (Johnson & Johnson) are both stocks. Both are in the Healthcare sector — VTRS in Drug Manufacturers - Specialty & Generic, JNJ in Drug Manufacturers - General. Over the past 5 years, VTRS returned 6.24%/yr vs 10.99%/yr for JNJ. At a 0.30 correlation, their price movements are largely independent.
Performance
VTRS vs. JNJ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VTRS achieves a 28.52% return, which is significantly higher than JNJ's 16.81% return.
VTRS
- 1D
- 2.41%
- 1M
- -5.41%
- YTD
- 28.52%
- 6M
- 33.12%
- 1Y
- 84.98%
- 3Y*
- 22.46%
- 5Y*
- 6.24%
- 10Y*
- —
JNJ
- 1D
- 3.37%
- 1M
- 2.61%
- YTD
- 16.81%
- 6M
- 17.47%
- 1Y
- 61.94%
- 3Y*
- 16.40%
- 5Y*
- 10.99%
- 10Y*
- 10.52%
VTRS vs. JNJ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
VTRS Viatris Inc. | 28.52% | 5.08% | 19.68% | 2.06% | -14.29% | -26.12% | 19.82% |
JNJ Johnson & Johnson | 16.81% | 47.48% | -4.81% | -8.58% | 5.97% | 11.44% | 5.72% |
Correlation
The correlation between VTRS and JNJ is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Nov 16, 2020 | 0.30 |
Fundamentals
VTRS:
$18.51B
JNJ:
$584.60B
VTRS:
-$0.25
JNJ:
$8.65
VTRS:
1.26
JNJ:
6.04
VTRS:
1.26
JNJ:
7.20
VTRS:
$14.56B
JNJ:
$96.36B
VTRS:
$5.01B
JNJ:
$66.60B
VTRS:
$1.89B
JNJ:
$31.62B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VTRS vs. JNJ — Risk / Return Rank
VTRS
JNJ
VTRS vs. JNJ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Viatris Inc. (VTRS) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VTRS | JNJ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.95 | ||
| Sortino ratioReturn per unit of downside risk | -1.51 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 1.64 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | 4.50 | 5.68 | -1.18 |
| Martin ratioReturn relative to average drawdown | 12.59 | 16.53 | -3.94 |
Loading charts...
Drawdowns
VTRS vs. JNJ - Drawdown Comparison
The maximum VTRS drawdown since its inception was -54.33%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for VTRS and JNJ.
Loading charts...
Drawdown Indicators
| VTRS | JNJ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -54.33% | -50.67% | -3.66% |
Max Drawdown (1Y)Largest decline over 1 year | -18.97% | -10.96% | -8.01% |
Max Drawdown (3Y)Largest decline over 3 years | -45.02% | -15.95% | -29.07% |
Max Drawdown (5Y)Largest decline over 5 years | -45.69% | -18.41% | -27.28% |
Max Drawdown (10Y)Largest decline over 10 years | — | -27.37% | — |
Current DrawdownCurrent decline from peak | -8.77% | -3.26% | -5.51% |
Average DrawdownAverage peak-to-trough decline | -30.64% | -11.90% | -18.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.77% | 3.76% | +3.01% |
Volatility
VTRS vs. JNJ - Volatility Comparison
Viatris Inc. (VTRS) has a higher volatility of 8.31% compared to Johnson & Johnson (JNJ) at 7.05%. This indicates that VTRS's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VTRS | JNJ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.31% | 7.05% | +1.26% |
Volatility (6M)Calculated over the trailing 6-month period | 23.74% | 12.69% | +11.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.45% | 17.40% | +15.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.43% | 16.99% | +16.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.89% | 18.54% | +15.35% |
Dividends
VTRS vs. JNJ - Dividend Comparison
VTRS's dividend yield for the trailing twelve months is around 3.05%, more than JNJ's 2.19% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 2.19% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
VTRS Viatris Inc. | 3.05% | 3.86% | 3.86% | 4.43% | 4.31% | 2.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
VTRS vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Viatris Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VTRS vs. JNJ - Profitability Comparison
VTRS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Viatris Inc. reported a gross profit of 1.16B and revenue of 3.52B. Therefore, the gross margin over that period was 32.9%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.
VTRS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Viatris Inc. reported an operating income of -79.70M and revenue of 3.52B, resulting in an operating margin of -2.3%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.
VTRS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Viatris Inc. reported a net income of 176.40M and revenue of 3.52B, resulting in a net margin of 5.0%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.
Frequently Asked Questions
VTRS and JNJ have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VTRS has higher volatility (8.31%) compared to JNJ (7.05%). In terms of maximum drawdown, VTRS dropped -54.33% vs JNJ's -50.67%.
JNJ currently has the higher Sharpe Ratio (3.58 vs 2.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VTRS and JNJ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer